Medicare Enrolled
Dr. Mary Davidian, MD
Ophthalmology · New Windsor, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Davidian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Davidian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Davidian
Dr. Mary Davidian is an ophthalmology specialist in New Windsor, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Davidian performed 2,263 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Davidian received a total of $36,375 from 45 pharmaceutical and/or device companies across 455 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Davidian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 43% volume in NY
$36,375 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,263
Medicare services
Top 43% in NY for ophthalmology
Not available
Unique patients (not deduplicated)
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
453 | $94 | $175 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
265 | $34 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
234 | $69 | $125 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
231 | $31 | $250 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
215 | $69 | $125 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
186 | $447 | $3,031 |
| CT scan of cornea A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye. |
120 | $27 | $80 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
117 | $26 | $248 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
97 | $120 | $200 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
88 | $46 | $148 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
77 | $278 | $2,000 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
58 | $26 | $250 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
30 | $20 | $100 |
| Eye photography Photographic imaging of the interior structures of the eye. |
29 | $20 | $51 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
19 | $9 | $50 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
18 | $614 | $4,000 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $65 | $150 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
12 | $93 | $175 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
8.2% high complexity
21.5% medium
70.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$36,375
Total received (2018-2024)
Avg $5,196/year across 7 years
Top 4% in NY for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
455
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,964
2023
$6,865
2022
$2,419
2021
$6,218
2020
$557
2019
$9,484
2018
$6,867
Payments by company (2024)
BIOTISSUE HOLDINGS INC.
$1,587
LENSAR, Inc.
$428
ABBVIE INC.
$400
Bausch & Lomb Americas Inc.
$232
Harrow Eye, LLC
$202
Alcon Vision LLC
$173
Dompe US, Inc.
$166
Mallinckrodt Hospital Products Inc.
$139
Oyster Point Pharma, Inc.
$134
Tarsus Pharmaceuticals, Inc.
$127
SUN PHARMACEUTICAL INDUSTRIES INC.
$119
Sight Sciences, Inc.
$76
Carl Zeiss Meditec USA, Inc.
$43
Rayner Intraocular Lenses Limited
$31
Glaukos Corporation
$30
Amgen Inc.
$27
CooperVision Inc.
$25
ANI Pharmaceuticals, Inc.
$25
Top 3 companies account for 60.9% of 2024 payments
All-time payments by company (2018-2024) ›
Dompe US, Inc.
$14,218
TissueTech, Inc.
$5,469
Shire North American Group Inc
$5,267
BIOTISSUE HOLDINGS INC.
$1,587
Alcon Vision LLC
$1,036
Sun Pharmaceutical Industries Inc.
$760
Sight Sciences, Inc.
$675
ABBVIE INC.
$604
Oyster Point Pharma, Inc.
$528
Mallinckrodt Hospital Products Inc.
$508
Aerie Pharmaceuticals, Inc.
$472
Bausch & Lomb, a division of Bausch Health US, LLC
$457
LENSAR, Inc.
$428
Novartis Pharmaceuticals Corporation
$406
Allergan Inc.
$404
Bausch & Lomb Americas Inc.
$335
Johnson & Johnson Surgical Vision, Inc.
$319
Allergan, Inc.
$305
Kala Pharmaceuticals, Inc.
$280
AbbVie Inc.
$235
SUN PHARMACEUTICAL INDUSTRIES INC.
$220
Harrow Eye, LLC
$202
EyePoint Pharmaceuticals US, Inc.
$181
BIOTISSUE HOLDINGS, INC.
$176
Horizon Therapeutics plc
$157
Tarsus Pharmaceuticals, Inc.
$127
BioTissue Holdings, Inc.
$123
NEW WORLD MEDICAL,INC.
$112
Eyevance Pharmaceuticals LLC
$97
Iridex Corporation
$81
RxSight Inc
$78
Mallinckrodt LLC
$76
ANI Pharmaceuticals, Inc.
$56
Alcon Laboratories Inc
$51
Omeros Corporation
$49
Carl Zeiss Meditec USA, Inc.
$43
TISSUETECH, INC.
$41
Mallinckrodt Enterprises LLC
$33
Rayner Intraocular Lenses Limited
$31
Glaukos Corporation
$30
Amgen Inc.
$27
CooperVision Inc.
$25
Ocular Therapeutix, Inc.
$24
Thea Pharma Inc.
$22
Carl Zeiss Meditec AG
$19
Top 3 companies account for 68.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ALPHAGAN P · ARGOS · ARTEVO 800 · AcrySof IQ PanOptix · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · Ahmed Glaucoma Valve · BESIVANCE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · COMBIGAN · Cequa · Clareon · DEXTENZA · DEXYCU · DUREZOL · DURYSTA · ENVISTA ENVY · Flarex · HYDRUS Microstent · IHEEZO · ILUX · INVELTYS · LENSAR LASER SYSTEM · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX · LOTEMAX SM · LUMIGAN · MIEBO · MiSight Contact Lens · None Specified · OMNI · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · ORA · OXERVATE · Omidria · Oxervate · PROKERA · PROLENSA · PURIFIED CORTROPHIN GEL · Photrexa · Prokera · RESTASIS · RESTASIS MULTIDOSE · ReSTOR · Rhopressa · Rocklatan · Simbrinza · TEARCARE SYSTEM · TECNIS IOL · TEPEZZA · TRAVATAN Z · TYRVAYA · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Symfony IOL · Tobradex ST · VEVYE · VUITY · VYZULTA · XDEMVY · XIIDRA · ZYLET · Zerviate · enVista MX60 IOL · rhopressa · rocklatan
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Ophthalmologists in nearby ZIP areas
75
County median income
$96,497
Nearest hospital to ZIP centroid (approximate)
MONTEFIORE ST LUKE'S CORNWALL
5.5 mi
5.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Davidian is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Davidian experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Davidian performed 453 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Davidian receive payments from pharmaceutical companies?
Yes. Dr. Davidian received a total of $36,375 from 45 companies across 455 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Davidian's costs compare to other ophthalmologists in New Windsor?
Dr. Davidian's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Davidian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in New Windsor
Browse ophthalmologists in New Windsor ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in NY
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in NY
Which NY ophthalmologists receive the most from drug and device companies.
By company
Dompe US, Inc. Payments to Doctors
See all physicians who received payments from Dompe US, Inc.
By company
TissueTech, Inc. Payments to Doctors
See all physicians who received payments from TissueTech, Inc.
By company
Shire North American Group Inc Payments to Doctors
See all physicians who received payments from Shire North American Group Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology